CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade Estadual de Campinas (UNICAMP). Faculdade de Ciências Farmacêuticas (FCF) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Bachelor's at Ciências Biológicas Modalidade Médica from Universidade Federal de São Paulo (1978), master's at Pharmacology from Universidade Federal de São Paulo (1983) and doctorate at Pharmacology from Universidade Federal de São Paulo (1992). Has experience in Pharmacology, acting on the following subjects: anticâncer, antiulcerogênico, plantas medicinais, artemisia annua and anticancer. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The Faculty of Pharmaceutical Sciences is UNICAMP's newest unit and started its operations in the second half of 2014. Its teaching staff consists of 16 full-time professors, including three full professors, four associate professors, nine doctored professors and one researcher. FCF has 238 Pharmacy undergraduate students and 25 Postgraduate students in Pharmaceutical Sciences, being 13 M…
The Faculty of Pharmaceutical Sciences (FCF) is UNICAMP's youngest faculty, having started its operation in the second half of 2014. The faculty has currently 16 lecturers (three Full Professors, three Associate Professors and 10 Assistant Professors) at full-time contracts, and 217 students enrolled in the undergraduate degree in Pharmacy. The Postgraduate courses, both in Master and Doc…
The Centro Pluridisciplinar de Pesquisas Químicas, Biológicas e Agrícolas (CPQBA) is composed of the following Divisions: Agro-technology, Phytochemistry, Organic Chemistry and Pharmaceutics, Pharmacology and Toxicology, Microbiology, Residues, Biotechnology and Microbial Resources. Due to its multidisciplinary aspect, most of the research projects are developed in an integrated way, invo…
Over the past three decades microorganisms have been studied as a promising source of bioactive molecules opening up wide possibilities for the use in the pharmaceutical industry related to the treatment of several diseases. Recent researches indicate that a significant number of new bioactive natural products are products derived from interactions between these organisms with their respe…
In the last three decades, microorganisms have been studied as a promising source of bioactive molecules with wide possibilities of use in the pharmaceutical industry in the treatment of various diseases. In this work, different phytopathogenic fungi will be studied in relation to the production of bioactive secondary metabolites, being 4 strains of the genus Penicillium. All strains will…
The research of active ingredients from natural sources has allowed the discovery and development of many chemotherapeutic drugs used in cancer treatment. Currently about 60% of anticancer drugs are derived from natural products, demonstrating the great potential of these products in the research and development of new drugs for the treatment of this group of diseases. The Multidisciplina…
(Only some records are available in English at this moment)
According to statistical data from 1946 to Sep/2019, there are 13.5% and 25.1% of anticancer drugs originating and derived from natural products, respectively. Epicoccum sp. is a genus of ubiquitous ascomycetes belongs to the Didymellaceae family and known to produce a wide variety of biologically and chemically useful compounds, such as polyketides, diketopiperazines, polyketide hybrids …
There were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer in 2012 worldwide and the most incident types were lung (13%), breast (11.9%) and colorectal cancer (9.7%), with 19.4%, 6.4% and 8.5% of mortality respectively. In this context, natural products are an important source of new active compounds. More than 50% of the chemotherapies …
The dimethoxylated derivative of goniothalamin (diOMe-GTN), the target of the post-doctoral study of the candidate (FAPESP 2013/15946-7), showed promising in vitro antiproliferative activity for various tumor cell lines, in particular to those derived from human breast cancer MCF-7, MDA-MB-231 and MCF-7/BUS cells. Its effect on the cell cycle, as well as on the mechanism of cell death, on…
| 5 / 3 | Completed research grants |
| 30 / 12 | Completed scholarships in Brazil |
| 3 / 3 | Completed scholarships abroad |
| 38 / 18 | All research grants and scholarships |
| Associated processes | |